Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database.

Kotake, Kazumasa; Mitsuboshi, Satoru; Omori, Yuki; Kawakami, Yukio; Kawakami, Yasuhiro

Kotake, Kazumasa; Mitsuboshi, Satoru; Omori, Yuki; Kawakami, Yukio; Kawakami, Yasuhiro.

Afiliación

Kotake K; Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan.
Mitsuboshi S; Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
Omori Y; Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan.
Kawakami Y; Department of Orthopedic Surgery, Okayama Saiseikai General Hospital, Okayama, Japan.
Kawakami Y; Department of Pharmacy, Okayama Saiseikai General Hospital, Okayama, Japan.

J Pharm Technol ; 39(1): 23-28, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36755759

Palabras clave

cardiac event; cerebrovascular event; comorbidity; osteoporosis; romosozumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Technol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google